Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4349)
All Articles published online
|
Publishing Process of This Article
|
2021-02-28 (publication date) through 2024-04-20
Times Cited of This Article
Journal Information of This Article
Publication Name
世界华人消化杂志
ISSN
1009-3079
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 黄健翔, 骆旭航, 龚安安. 卡瑞利珠单抗配合TACE对伴微血管侵犯肝细胞癌患者根治术后血清Egfl7、VEGF、OPN水平及复发率影响的前瞻性研究. 世界华人消化杂志 2021; 29(4): 182-189 [DOI: 10.11569/wcjd.v29.i4.182] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i4/182.htm |
| Number | Citing Articles |
| 1 |
Qing Yang, Gengyu Li, Xiaoqiu Wu, Haiying Lin, Wanrui Wu, Xiangpang Xie, Yu Zhu, Wei Cai, Changsheng Shi, Shengye Zhuo. RETRACTED: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1136366
|
| 2 |
Sujing Zhang, Yingchun Zhao, Li He, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Ying Guo, Yan Guo, Changwang Zhang. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101851 doi: 10.1016/j.clinre.2021.101851
|